Background: Cell-free DNA(cf-DNA) has been described as an effectived biomarker in autoimmune disease, which mainly due to the release of apoptotic cells. In this study, we hypothesized and explored the relationship between cf-DNA and the influencing factors of the appearance and development of schizophrenia, so as to provide the basis for further research, prevention and treatment. Methods: We analysed and compared the concentration of cf-DNA in 174 schizophrenia patients and matched 100 healthy controls using quantitative real-time PCR by amplifying the Alu repeats. Results: We found that cf-DNA levels in peripheral blood reliably distinguished schizophrenia from a normal control group. In addition, we found by tracking the median absolute concentration of serum cf-DNA in primary cases, we found a distinct increase at prior treatment and it then decreased progressively at post treatment. Conclusions: Our study quantified cf-DNA in SZ patients serum by using conventional RT-qPCR. The detection of cf-DNA concentration was valuable for monitoring disease duration of SZ patients and laid a foundation for the study of the molecular mechanism of SZ disease.